InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $30.030 0.28 (0.92%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17,838 Notice of Proposed Sale of Securities 4 Jun 2025 8:22AM $37.930 $30.030 fallen by 20.83%
$17,838 Notice of Proposed Sale of Securities 4 Jun 2025 8:22AM $37.930 $30.030 fallen by 20.83%
$17,838 FORM SD 30 May 2025 8:21AM $38.240 $30.030 fallen by 21.47%
$17,838 Statement of Changes in Beneficial Ownership 28 May 2025 8:17AM $38.130 $30.030 fallen by 21.24%
$17,838 Notice of Proposed Sale of Securities 23 May 2025 8:19AM $38.240 $30.030 fallen by 21.47%
$17,838 Statement of Changes in Beneficial Ownership 23 May 2025 8:19AM $38.240 $30.030 fallen by 21.47%
$17,838 Notice of Proposed Sale of Securities 22 May 2025 8:18AM $38.650 $30.030 fallen by 22.30%
$17,838 Update - Dividend/Distribution - RMD 12 May 2025 8:16AM $38.190 $30.030 fallen by 21.37%
$17,838 Statement of Changes in Beneficial Ownership 12 May 2025 8:15AM $38.190 $30.030 fallen by 21.37%
$17,838 Statement of Changes in Beneficial Ownership 9 May 2025 8:30AM $38.000 $30.030 fallen by 20.97%
$17,838 Notice of Proposed Sale of Securities 9 May 2025 8:30AM $38.000 $30.030 fallen by 20.97%
$17,838 Notice of Proposed Sale Of Securities 9 May 2025 8:30AM $38.000 $30.030 fallen by 20.97%
$17,838 Statement of CDIs on issue - RMD 6 May 2025 10:18AM $37.310 $30.030 fallen by 19.51%
$17,838 Form 10-Q for the Quarter Ended March 31, 2025 28 Apr 2025 8:08AM $36.080 $30.030 fallen by 16.77%
$17,838 Dividend/Distribution - RMD 24 Apr 2025 8:18AM $33.250 $30.030 fallen by 9.68%
$17,838 Resmed Announces Results for the Third Quarter of FY2025 24 Apr 2025 8:17AM $33.250 $30.030 fallen by 9.68%
$17,838 Statement of changes in beneficial ownership of securities 15 Apr 2025 8:25AM $33.610 $30.030 fallen by 10.65%
$17,838 Notice of Proposed Sale of Securities 9 Apr 2025 8:20AM $34.920 $30.030 fallen by 14%
$17,838 Notice of Proposed Sale of Securities 8 Apr 2025 8:21AM $33.460 $30.030 fallen by 10.25%
$17,838 Statement of changes in beneficial ownership 7 Apr 2025 8:17AM $33.860 $30.030 fallen by 11.31%
$17,838 Statement of CDIs on issue - RMD 4 Apr 2025 1:24PM $33.820 $30.030 fallen by 11.21%
$17,838 Form 4 - Statement of Changes in Beneficial Ownership 4 Apr 2025 8:20AM $34.780 $30.030 fallen by 13.66%
$17,838 Report of proposed sale of securities 3 Apr 2025 10:11AM $34.790 $30.030 fallen by 13.68%
$17,838 ResMed to Report Third Quarter Fiscal 2025 Results 3 Apr 2025 8:22AM $35.260 $30.030 fallen by 14.83%
$17,838 Report of proposed sale of securities 2 Apr 2025 8:24AM $35.630 $30.030 fallen by 15.72%

151 - 175 of 703 results

Page 7 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.